The scene is simple, almost ordinary: someone who tries to quit smoking and finds himself after a few hours with restless hands, a racing head, and a lack of sleep. That’s where everything often gets stuck. Not in the decision, but in the holding.
A concrete novelty fits into this difficult space: in Italy cytisine becomes reimbursable by the National Health Service. It’s not a technical detail. It means that a pharmacological treatment for tobacco cessation finally enters the public perimeter, with regulated access and without the direct burden of cost for those who need it.
The Italian Medicines Agency had given the green light in December, and now the measure has become operational with its publication in the Official Journal. Cytisine was already present in the indications of the World Health Organization in 2024 and has been used for some time in several European countries. Now it also finds space in Italian routes.
A drug that works on the mechanisms of addiction
Cytisine acts on the same receptors involved in the effect of nicotine. It binds to those channels, occupies them, and lowers the intensity of the need. The result translates into a reduction of the most typical symptoms of withdrawal: irritability, anxiety, insomnia, difficulty concentrating. It doesn’t erase the addiction with a clear gesture, but dampens its impact, making the transition more sustainable.
The treatment has a specific duration, 25 days, and is part of a structured process, often connected to anti-smoking centres. It is not intended as an isolated solution, but as part of a broader work on de-addiction.
To get it for free you need to join a followed path
Here it is worth being clear, because the practical step makes all the difference. Cytisine is reimbursed by the National Health Service, but the free is activated within a real path: it requires treatment by an anti-smoking center identified in the area, with counseling and a therapeutic plan compiled by the center itself. AIFA has also set the limits: the reimbursable treatment concerns adult patients who want to stop smoking, it is valid for a single 25-day cycle, it covers one pack and that therapeutic plan is not renewable.
In concrete terms, those who want to access the drug without paying for it must therefore start from the anti-smoking centre, where they are assessed and placed in a structured process. To find the nearest one you can use the updated list of the Istituto Superiore di Sanità , which includes the centers present in Italy, or the Toll Free Telephone against Smoking 800 554 088, a free national service active from Monday to Friday from 10am to 4pm. Outside of this process, the drug remains prescribable, but the cost remains the responsibility of the patient.
Data from anti-smoking centers show concrete results
The numbers help you orient yourself. According to what was reported by Roberto Boffi, pulmonologist and director of the Anti-smoking Center of the National Cancer Institute of Milan, a study observed that 67% of patients stopped smoking three months after starting treatment, and 45% maintained abstinence after a year.
They are percentages that give a real measure of the effectiveness of the drug, within a followed clinical context. Boffi himself insists on a point that remains central: the path works better when pharmacological therapy is accompanied by psychological support. Nicotine addiction moves between habit, stress management, daily automatisms. The drug intervenes on part of the problem, the rest comes from deeper and more continuous work.
This opening of the Health Service shifts access from an individual choice to a concrete, more uniform possibility. It doesn’t solve everything, but it changes the ground on which you try to quit. And sometimes that’s enough: a little less friction on the days when giving up seems the easiest thing.
You might also be interested in:
